Australia Pharmaceuticals & Healthcare Report Q4 2014 - New Market Research Report
Over 300 drug formulations listed on the Pharmaceutical Benefits Scheme (PBS) will be subject to price reduction from October 1 2014, following the first simplified price disclosure (SPD) cycle in Australia. As a result, the prices of the affected drugs will be lowered by 20% on average, from those in April 2014. The Australian government continues to push price controls on pharmaceuticals. This is a reflection of the fact that high prices are no longer accepted by patients and national...
View full press release